Page 349 - IJB-10-2
P. 349

International Journal of Bioprinting                                 3D printing with drug for vascular repair




            fabricated ABV, we conducted an experiment to validate   the 3D-printed ABVs incorporating cells and drug-loaded
            the blood flow through ABV, and verified that blood vessels   nanoparticles was assessed.  The animal model of hindlimb
            were capable of reliable, sustained blood flow (Figure 4E).   ischemia created in this study was subjected to ABVs
            In addition to evaluating fluidity, we also investigated the   transplantation, and functional evaluation was performed
            impact of cell viability on blood vessel regeneration during   (Figure 5A). When only PBS without cells or ABVs were
            the transplantation of cell-loaded ABV. Cell viability   transplanted,  all  hindlimbs  of  the  treated  animals  were
            assessments were performed at multiple time points: 1, 3,   found to be necrotic. On the 14th day after transplantation,
            and 7 days. The results demonstrated consistent and stable   the group transplanted with ABVs without EPC or drug-
            cell viability throughout the observation period, indicating   loaded nanoparticles showed significant limb recovery
            the robustness of the cell-loaded ABVs in maintaining   (Figure 5B). During the follow-up period of up to 28 days,
            cell integrity and supporting potential tissue regeneration   we found that the treatment effect was sustained, similar to
            (Figure 4F). Further, mechanical properties of the vascular   that observed on the 14th day. Although the NP@BV group
            grafts such as burst pressure, compliance, and suture   manifested excellent effect, the laser Doppler perfusion
            retention were evaluated.  In this study, ABVs made from   imaging results confirmed that the EPC@NPSC@BV group
                                25
            alginate exhibited higher burst pressure values compared   on day 14 showed more profound effect. Most importantly,
            with those made solely from atelocollagen. However, due to   the group transplanted with ABVs, together with cells and
            the absence of cell adhesion ligands,  an ABV combining   nanoparticles, showed the most pronounced effect from
                                         73
            collagen and alginate was created to address the respective   the 7th day after transplantation (Figure 5C). This strong
            drawbacks  of  both materials  (Figure  4G).  Subsequently,   therapeutic effect on the hindlimb was attributed to both
            burst pressure measurements were conducted to assess   the cells and ABVs. The efficacy of vascular endothelial
            the burst pressure of cell-laden or cell-free ABVs, which   cells is an important factor contributing to the recovery
            were cultured for 7 days. The groups with cell-laden ABVs   of hindlimb over time; however, EPC@NPSC@BV
            (i.e., EPC@NPS@BV, EPC@NPC@BV, EPC@NPSC@           outperformed other counterparts in terms of the speed of
            BV) exhibited an improvement in burst pressure of more   recovery and the amount of blood flow during the recovery
            than threefold compared to the cell-free ABV group (i.e.,   period. We also analyzed foot necrosis after transplantation
            NP@BV) (Figure 4H). Next, to confirm continuous cell   (Figure  5D).  Similar  to  the  findings  mentioned  earlier,
            growth within the ABVs, fluorescence immunostaining   the highest incidence of necrosis was observed in the
            was employed to assess the expression of essential EPC   PBS and EPC groups. Notably, however, the EPC@NP@
            markers, such as CD31 and VE-cadherin (Figure 4I).   BV and EPC@NPSC@BV groups exhibited the most
            Additionally, the protein-level expression of CD31 and Ki-  promising therapeutic outcomes, promoting limb recovery
            67 was compared to that of two-dimensional (2D)-cultured   significantly faster than other groups (Figure 5E). This
            EPCs. It is noteworthy that when transitioning from a 2D   result is supported by the highest expression of α-SMA and
                                                               CD31, which are vascular-related markers, observed in the
            culture to a 3D culture environment, we observed a notable   EPC@NPSC@BV group (Figure 5F–I). In the final  part
            increase in the expression of endothelial cell-related   of the experiment, we determined the presence of ROS
            markers (Figure 4J). This expression increase of these   generation within the tissue  through DHE staining. We
            markers underscores the capacity of 3D culture systems   observed a significant reduction in DHE-positive staining
            in  establishing  a more physiologically  relevant  cellular   in the EPC@NPSC@BV group, consistent with the staining
            environment. Unlike traditional 2D cultures, 3D cultures   results for markers associated with blood vessels (Figure
            better mimic the natural microenvironment of cells   S2A and S2B in Supplementary File). Taken together, these
            within tissues and organs, allowing for improved cell–cell   results collectively suggest the potential utility of ABVs
            interactions and the formation of complex cell structures.   incorporating drug-loaded nanoparticles and EPCs in
            In this context, the enhanced expression of endothelial   mitigating the severity of ischemic diseases.
            cell-related markers suggests that our 3D culture model
            provides a more suitable platform for studying endothelial   4. Discussion
            cell behavior and function.
                                                               Despite the advancements in drug therapy and surgical
            3.4. In vivo transplantation of artificial blood vessels   procedures for the treatment of vascular diseases, several
            incorporating drugs-loaded nanoparticles in animal   notable disadvantages inherent in these approaches
            model                                              limit their long-term effectiveness. Drug therapy, while
            Based upon the aforementioned results, we conducted   offering  preventive  benefits,  often  requires  continuous
            in vivo experiments to validate the effects of drugs   administration, which may lead to side effects or drug
            encapsulated in nanoparticles. Furthermore, the stability of   resistance over time. Moreover, drug therapies may not


            Volume 10 Issue 2 (2024)                       341                                doi: 10.36922/ijb.1857
   344   345   346   347   348   349   350   351   352   353   354